ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 475

Myopenia in Elderly Female Patients with Rheumatoid Arthritis Is Associated with Severe Joint Damage: A Cross-sectional Study

Chu-Tao Chen 1, Jian-Zi Lin 1, Jian-Da Ma 1, Li-Juan Yang 1, Qian-Hua Li 1, Le-Feng Chen 1, Ying-Qian Mo 1 and Lie Dai1, 1Department of Rheumatology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China (People's Republic)

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: rheumatoid arthritis (RA) and Elderly

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: RA – Diagnosis, Manifestations, & Outcomes Poster I: Risk Factors, Predictors, & Prognosis

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Our previous study reported myopenia is associated with joint damage in rheumatoid arthritis (RA). However, little is known about body composition (BC) disorder in elderly patients with RA. Here we aimed to explore the characteristics of BC in elderly RA patients and their clinical significance.

Methods: Consecutive female patients with RA who fulfilled the 1987 revised criteria of ACR or 2010 ACR/EULAR classification criteria for RA were recruited from August 2015 to March 2018. Clinical data including disease activity, function and radiographic assessment were collected. BC was assessed by bioelectric impedance analysis. Overfat was defined by body fat percentage (BF%) as ≥35% in women. Myopenia was defined by appendicular skeletal muscle mass index (ASMI) ≤5.7kg/m2 in women.

Results: ①There were 425 female RA patients recruited with median age 50 (IQR 40, 58) years, median disease duration 60 (IQR 24, 120) months. There were 65.6% patients with active RA (DAS28-CRP≥2.6), 15.5% patients with functional limitation (HAQ-DI >1) and 56.5% with radiographic joint damage (RJD, mTSS >10). ②There were 23.1% elderly RA patients (age ≥60 years). Compared with young patients (age < 60 years), elderly RA patients had longer disease duration (median 92 months vs. 50 months), higher ESR (43 mm/h vs. 26mm/h), higher rate of functional limitation (24.5% vs. 12.8%) and RJD (67.2% vs. 51.0%), and higher rate of overfat (49.0% vs. 28.7%) and myopenia (54.1% vs. 41.9%, all P< 0.05). ③Compared with RA patients without myopenia, RA patients with myopenia (44.7%) had longer disease duration (median 72 months vs. 48 months), higher DAS28-CRP (median 3.48 vs. 3.02), higher rate of functional limitation (25.8% vs. 7.2%) and RJD (68.4% vs. 46.8%, all P< 0.05). ④There were 44.7% young patients without myopenia, 32.2% young patients with myopenia, 10.6% elderly patients without myopenia, and 12.5% elderly patients with myopenia. Elderly patients with myopenia had the highest rate of RJD (84.9%) in comparison with other three subgroups respectively. They also had higher rate of functional limitation (37.7%) when compared with young patients without myopenia as well as elderly patients without myopenia subgroups respectively (Table 1, all P< 0.0083, Bonferroni correction). ⑤After adjustment for confounding factors including age, smoking habits, disease duration, RF and ACPA status, multivariate logistic regression analysis showed that both young and elderly patients with myopenia had higher probabilities accompanied by functional limitation (young patients with myopenia: OR=3.479, 95%CI: 1.713~7.063; elderly patients with myopenia: OR=5.727, 95%CI: 2.467~13.292) and RJD (young patients with myopenia: OR=1.896, 95%CI: 1.171~3.068; elderly patients with myopenia: OR=4.627, 95%CI: 1.946~10.999) when compared with young patients without myopenia. Moreover, significant additive interaction was observed between the elderly and myopenia in RJD (AP=0.554, 95%CI: 0.125~0.983).

Conclusion: Elderly female patients with myopenia is associated with severe joint damage in rheumatoid arthritis and the underlying mechanism is worth further study.


Comparisons of disease characteristics among RA patients in age and myopenia subgroups

Table1. Comparisons of disease characteristics among RA patients in age and myopenia subgroups


Disclosure: C. Chen, None; J. Lin, None; J. Ma, None; L. Yang, None; Q. Li, None; L. Chen, None; Y. Mo, None; L. Dai, None.

To cite this abstract in AMA style:

Chen C, Lin J, Ma J, Yang L, Li Q, Chen L, Mo Y, Dai L. Myopenia in Elderly Female Patients with Rheumatoid Arthritis Is Associated with Severe Joint Damage: A Cross-sectional Study [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/myopenia-in-elderly-female-patients-with-rheumatoid-arthritis-is-associated-with-severe-joint-damage-a-cross-sectional-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/myopenia-in-elderly-female-patients-with-rheumatoid-arthritis-is-associated-with-severe-joint-damage-a-cross-sectional-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology